Victoria Lewis, DVM, RPH

Victoria Lewis has over 20 years of experience in clinical research and development of new animal health pharmaceuticals, medical devices, therapeutic diets and supplements.  She has specialized experience in development strategies, study design, study execution and regulatory reporting functions. She is an expert in medical writing, study protocols, final study reports, publications, expert reports, risk assessment reports and safety summaries for both New Animal Drug Applications (NADAs) and Abbreviated New Animal Drug Applications (ANADAs). She has provided companies with strategic regulatory advice including drafting development plans for NDAs, representation at FDA-CVM meetings, veterinary counsel and pharmacovigilance safety monitoring and reporting to the FDA-CVM. She has led all aspects of clinical development process for new drugs from Proof of Concept to regulatory filing for licensing approval. She has managed multiple aspects of study start up activities. She also has advanced training in routine and complex surgical procedures in equine and bovine patients. In specific consideration of her equine experience, she has had vast success in preforming lameness examinations for former equine athletes in order to provide appropriate treatments when necessary.

 

Victoria has held diversified roles in research, pharmacology, development, and quality assurance in both human health and animal health.  She has held management positions with organizations such as Triveritas, AlcheraBio, and Merck and pharmacology or research roles with organizations such as University of Pennsylvania, Massachusetts General, Parexel, Serono Laboratories and Novartis.

 

Victoria Lewis holds a DVM from Tuffs University School of Veterinary Medicine and a BS in Pharmacy from Massachusetts College of Pharmacy.

​